TrialJournal of internal medicine2021

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry.

G Savarese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.